Position
SYNTAX RESEARCH, INC. in Cvs Health Corp
Back to the book · All holders of CVS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.53K$79.36 → $71.82
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 371 | $29.4K | — | — | — | 0.0% |
| Q1 2026 | 203 | $14.6K | $71.82 | −$1.53K | −$13.3K | 0.0% |